SIREN : 807894498
NEW LAB is a French company founded 11 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in SAINT-OUEN-SUR-SEINE (93400), this company of category PME shows in 2022 a revenue of 3.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | 3 720 619 € | N/C | 2 444 295 € | 2 722 089 € | 2 076 336 € | 1 527 211 € | 823 276 € | 273 816 € |
| Net income | 318 587 € | 216 868 € | 507 366 € | 176 961 € | 196 742 € | 126 249 € | 7 297 € | 76 303 € | -13 275 € |
| EBITDA | N/C | 315 360 € | N/C | 171 828 € | 296 590 € | 171 322 € | 17 170 € | 105 264 € | -11 165 € |
| Net margin | N/C | 5.8% | N/C | 7.2% | 7.2% | 6.1% | 0.5% | 9.3% | -4.8% |
In 2023, NEW LAB generates positive net income of 319 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
318 587 €
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
23.5%
55.916%
42.2%
In 2023, the debt ratio of NEW LAB (23.50) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2023, the financial autonomy of NEW LAB (55.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2022, the repayment capacity of NEW LAB (1.15) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 312.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
312.98
In 2023, the liquidity ratio of NEW LAB (312.98) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2022, the interest coverage of NEW LAB (4.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 57 transactions of similar company sales
(all years),
the value of NEW LAB is estimated at
970 314 €
(range 225 488€ - 1 913 416€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NEW LAB with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of NEW LAB in 2022 is 3.7 M€.
Yes, NEW LAB generated a net profit of 319 k€ in 2023.
The headquarters of NEW LAB is located in SAINT-OUEN-SUR-SEINE (93400), in the department Seine-Saint-Denis.
The tax return of NEW LAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NEW LAB operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.